+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Pharmaceutical Traceability Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F

  • PDF Icon

    Report

  • 185 Pages
  • May 2026
  • Region: Global
  • TechSci Research
  • ID: 5908201
Free Webex Call
10% Free customization

Barcode is the fastest growing sector, North America is the largest market

Free Webex Call

Speak directly to the analyst to clarify any post sales queries you may have.

10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.

The Global Pharmaceutical Traceability Market is projected for substantial growth, expanding from USD 22.13 billion in 2025 to USD 62.91 billion by 2031, at a 19.02% compound annual growth rate. This market encompasses an integrated network of software, hardware, and standards developed to track and trace prescription medications across the entire supply chain, thereby ensuring product authenticity from the manufacturer to the point of dispensing.

Market Drivers

This expansion is primarily propelled by the enforcement of stringent global serialization and traceability mandates, including regulations like the Drug Supply Chain Security Act in the US and the Falsified Medicines Directive in Europe. These regulatory pressures compel manufacturers and supply chain stakeholders to adopt interoperable compliance platforms to secure the supply chain against illegitimate products, as evidenced by rapid industry shifts toward digital compliance solutions. Concurrently, the rising prevalence of counterfeit drugs and pharmaceutical theft, along with increasing pharmaceutical recall events, critically necessitates advanced visibility solutions not only for verifying authenticity but also for efficiently managing safety events and improving overall patient safety.

Market Challenges

Despite this progress, a significant impediment to broader market expansion remains the high cost and technical complexity associated with establishing full interoperability across diverse stakeholder systems. Smaller and mid-sized entities frequently lack the financial resources to upgrade infrastructure, leading to difficulties in maintaining the rigorous data integrity required for seamless compliance. This operational friction, highlighted by 70 percent of logistics operations experiencing weekly barcode readability issues, necessitates expensive manual interventions and diminishes the return on investment for traceability technologies, thereby hindering the market's ability to achieve universal visibility required for robust growth.

Market Trends

Nevertheless, the market is undergoing a transformative shift driven by key technological trends. The adoption of artificial intelligence for predictive supply chain analytics is notably transforming operations from reactive monitoring to proactive resilience, enabling stakeholders to anticipate disruptions through machine learning algorithms and leverage serialization data for strategic risk management beyond solely regulatory adherence. Simultaneously, the market is witnessing increased momentum in the adoption of GS1 Digital Link and 2D barcodes. These advanced data carriers embed richer, granular details like expiration dates and batch numbers within a single scan, facilitating enhanced information exchange and streamlining complex logistics beyond fundamental compliance mandates, ultimately contributing to improved visibility and interoperable standardization.

Key Market Players

  • Optel Group
  • The Healthcare Distribution Alliance (HDA)
  • Bureau Veritas SA
  • Logista Pharma SA
  • Rfxcel Corp
  • Movilitas Consulting AG
  • TraceLink Inc
  • Avery Dennison Corp
  • Cognex Corp

Report Scope

In this report, the Global Pharmaceutical Traceability Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Pharmaceutical Traceability Market, by Type:

  • Barcode
  • GPS
  • RFID

Pharmaceutical Traceability Market, by End-User:

  • Hospitals
  • Pharmacies
  • Ambulatory Care Centers

Pharmaceutical Traceability Market, by Region:

  • North America
  • Europe
  • Asia Pacific
  • South America
  • Middle East & Africa

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Pharmaceutical Traceability Market.

Available Customizations:

With the given market data, the publisher offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

This product will be delivered within 1-3 business days.

Table of Contents

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Pharmaceutical Traceability Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Type (Barcode, GPS, RFID)
5.2.2. By End-User (Hospitals, Pharmacies, Ambulatory Care Centers)
5.2.3. By Region
5.2.4. By Company (2025)
5.3. Market Map
6. North America Pharmaceutical Traceability Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Type
6.2.2. By End-User
6.2.3. By Country
6.3. North America: Country Analysis
6.3.1. United States Pharmaceutical Traceability Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Type
6.3.1.2.2. By End-User
6.3.2. Canada Pharmaceutical Traceability Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Type
6.3.2.2.2. By End-User
6.3.3. Mexico Pharmaceutical Traceability Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Type
6.3.3.2.2. By End-User
7. Europe Pharmaceutical Traceability Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Type
7.2.2. By End-User
7.2.3. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Pharmaceutical Traceability Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Type
7.3.1.2.2. By End-User
7.3.2. France Pharmaceutical Traceability Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Type
7.3.2.2.2. By End-User
7.3.3. United Kingdom Pharmaceutical Traceability Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Type
7.3.3.2.2. By End-User
7.3.4. Italy Pharmaceutical Traceability Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Type
7.3.4.2.2. By End-User
7.3.5. Spain Pharmaceutical Traceability Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Type
7.3.5.2.2. By End-User
8. Asia Pacific Pharmaceutical Traceability Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Type
8.2.2. By End-User
8.2.3. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Pharmaceutical Traceability Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Type
8.3.1.2.2. By End-User
8.3.2. India Pharmaceutical Traceability Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Type
8.3.2.2.2. By End-User
8.3.3. Japan Pharmaceutical Traceability Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Type
8.3.3.2.2. By End-User
8.3.4. South Korea Pharmaceutical Traceability Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Type
8.3.4.2.2. By End-User
8.3.5. Australia Pharmaceutical Traceability Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Type
8.3.5.2.2. By End-User
9. Middle East & Africa Pharmaceutical Traceability Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Type
9.2.2. By End-User
9.2.3. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Pharmaceutical Traceability Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Type
9.3.1.2.2. By End-User
9.3.2. UAE Pharmaceutical Traceability Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Type
9.3.2.2.2. By End-User
9.3.3. South Africa Pharmaceutical Traceability Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Type
9.3.3.2.2. By End-User
10. South America Pharmaceutical Traceability Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Type
10.2.2. By End-User
10.2.3. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Pharmaceutical Traceability Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Type
10.3.1.2.2. By End-User
10.3.2. Colombia Pharmaceutical Traceability Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Type
10.3.2.2.2. By End-User
10.3.3. Argentina Pharmaceutical Traceability Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Type
10.3.3.2.2. By End-User
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. Global Pharmaceutical Traceability Market: SWOT Analysis
14. Porter's Five Forces Analysis
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. Competitive Landscape
15.1. Optel Group
15.1.1. Business Overview
15.1.2. Products & Services
15.1.3. Recent Developments
15.1.4. Key Personnel
15.1.5. SWOT Analysis
15.2. The Healthcare Distribution Alliance (HDA)
15.3. Bureau Veritas SA
15.4. Logista Pharma SA
15.5. Rfxcel Corp
15.6. Movilitas Consulting AG
15.7. TraceLink Inc
15.8. Avery Dennison Corp
15.9. Cognex Corp
16. Strategic Recommendations17. About the Publisher & Disclaimer

Companies Mentioned

  • Optel Group
  • The Healthcare Distribution Alliance (HDA)
  • Bureau Veritas SA
  • Logista Pharma SA
  • Rfxcel Corp
  • Movilitas Consulting AG
  • TraceLink Inc
  • Avery Dennison Corp
  • Cognex Corp

Table Information